In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach

Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the novel SARS-CoV-2 evade the host innate immunity, and subsequently the adaptive immune response, employing one protease called Papain-like protease (PLpro). The PLpro and the 3CL...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Shuvasish, Moulick, Debojyoti, Borah, Anupom, Saikia, Purbajyoti, Mazumder, Muhammed Khairujjaman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019474/
https://www.ncbi.nlm.nih.gov/pubmed/33842190
http://dx.doi.org/10.1007/s40203-021-00085-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019474/
https://www.ncbi.nlm.nih.gov/pubmed/33842190
http://dx.doi.org/10.1007/s40203-021-00085-y

Ejemplares similares